AAAAAA
Results:
1-17
|
Results: 17
Authors:
SMITH CA
WOODRUFF LS
ROONEY C
KITCHINGMAN GR
Citation: Ca. Smith et al., EXTENSIVE CROSS-REACTIVITY OF ADENOVIRUS-SPECIFIC CYTOTOXIC T-CELLS, Human gene therapy, 9(10), 1998, pp. 1419-1427
Authors:
ROONEY C
BANGERT CE
Citation: C. Rooney et Ce. Bangert, COMPUTERS IN THE COATINGS INDUSTRY - THE NEXT 10 YEARS, JCT, Journal of coatings technology, 70(876), 1998, pp. 103-106
Authors:
KITCHINGMAN GR
ROONEY C
Citation: Gr. Kitchingman et C. Rooney, CYTOTOXIC T-CELLS AND IMMUNOTHERAPY, Pediatric radiology, 28(7), 1998, pp. 489-491
Authors:
ROONEY C
MCMICHAEL AJ
KOVATS RS
COLEMAN MP
Citation: C. Rooney et al., EXCESS MORTALITY IN ENGLAND AND WALES, AND IN GREATER LONDON, DURING THE 1995 HEATWAVE, Journal of epidemiology and community health, 52(8), 1998, pp. 482-486
Authors:
ROONEY C
Citation: C. Rooney, INCREASE IN US MEDICATION-ERROR DEATHS, Lancet, 351(9116), 1998, pp. 1656-1657
Authors:
AJAYIOBE EK
LODI E
ALKALI AS
GALBATI M
ROONEY C
MANNONI B
GRIM P
NASIDI A
MOHAMMED I
Citation: Ek. Ajayiobe et al., PROGNOSTIC SCORES FOR USE IN AFRICAN MENINGOCOCCAL EPIDEMICS, Bulletin of the World Health Organization, 76(2), 1998, pp. 149-152
Authors:
THOMPSON JW
BRENNER M
ROONEY C
Citation: Jw. Thompson et al., IMMUNE THERAPY (SENSITIZED LYMPHOCYTES) FOR LARYNGEAL PAPILLOMATOSIS - A PROGRESS REPORT, Pediatrics (Evanston), 102(3), 1998, pp. 748-748
Authors:
ROONEY C
SMITH C
ROSKROW M
BRENNER M
HESLOP H
Citation: C. Rooney et al., IMMUNOTHERAPY FOR EBV-ASSOCIATED LYMPHOPROLIFERATIVE DISEASE, Journal of acquired immune deficiency syndromes and human retrovirology, 14(4), 1997, pp. 18-18
Authors:
ROONEY C
Citation: C. Rooney, ELIMINATION OF FIREARMS - AUTHOR GAVE UNDERESTIMATE OF DEATHS DUE TO FIREARMS, BMJ. British medical journal, 315(7114), 1997, pp. 1020-1020
Authors:
ROONEY C
Citation: C. Rooney, CLANDESTINE ANTIGONES (POSTCOLONIAL THEORY, GENEALOGIES), Oxford literary review, 19(1-2), 1997, pp. 47-78
Authors:
BRENNER MK
HESLOP HE
RILL D
LI CF
SMITH C
KRANCE R
ROONEY C
Citation: Mk. Brenner et al., TRANSFER OF MARKER GENES INTO HEMATOPOIETIC PROGENITOR CELLS, Cytokines and molecular therapy, 2(3), 1996, pp. 193-200
Authors:
HESLOP HE
BRENNER MK
ROONEY C
KRANCE RA
ROBERTS WM
ROCHESTER R
SMITH CA
TURNER V
SIXBEY J
MOEN R
BOYETT JM
Citation: He. Heslop et al., ADMINISTRATION OF NEOMYCIN RESISTANCE GENE MARKED EBV SPECIFIC CYTOTOXIC T-LYMPHOCYTES TO RECIPIENTS OF MISMATCHED-RELATED OR PHENOTYPICALLY SIMILAR UNRELATED DONOR MARROW GRAFTS, Human gene therapy, 5(3), 1994, pp. 381-397
Authors:
BRENNER MK
HESLOP HE
RILL D
LI C
NILSON T
ROBERTS M
SMITH C
KRANCE R
ROONEY C
Citation: Mk. Brenner et al., GENE-TRANSFER AND BONE-MARROW TRANSPLANTATION, Cold Spring Harbor Symposia on Quantitative Biology, 59, 1994, pp. 691-697
Authors:
ROONEY C
BERAL V
MACONOCHIE N
FRASER P
DAVIES G
Citation: C. Rooney et al., CASE-CONTROL STUDY OF PROSTATIC-CANCER IN EMPLOYEES OF THE UNITED-KINGDOM-ATOMIC-ENERGY-AUTHORITY, BMJ. British medical journal, 307(6916), 1993, pp. 1391-1397
Authors:
SEAGROATT V
ROONEY C
Citation: V. Seagroatt et C. Rooney, SUICIDE IN DOCTORS, BMJ. British medical journal, 307(6901), 1993, pp. 447-447
Authors:
SHENKER BJ
MAYRO JS
ROONEY C
VITALE L
SHAPIRO IM
Citation: Bj. Shenker et al., IMMUNOTOXIC EFFECTS OF MERCURIC COMPOUNDS ON HUMAN-LYMPHOCYTES AND MONOCYTES .4. ALTERATIONS IN CELLULAR GLUTATHIONE CONTENT, Immunopharmacology and immunotoxicology, 15(2-3), 1993, pp. 273-290
Authors:
MAHMOUD H
BRENNER M
ROONEY C
HESLOP H
KRANCE R
Citation: H. Mahmoud et al., ANTI-CD21 AND CD24 MONOCLONAL-ANTIBODY THERAPY (ANTI-CD21 24) FOR B-CELL LYMPHOPROLIFERATIVE DISEASE (LPD) FOLLOWING BONE-MARROW TRANSPLANTATION (BMT)/, Blood, 82(10), 1993, pp. 10000636-10000636
Risultati:
1-17
|